Current progress in NK cell biology and NK cell-based cancer immunotherapy

Cancer Immunology, Immunotherapy : CII
Raquel TarazonaRafael Solana

Abstract

A better understanding of the complex interactions between the immune system and tumour cells from different origins has opened the possibility to design novel procedures of antitumoral immunotherapy. One of these novel approaches is based on the use of autologous or allogeneic natural killer (NK) cells to treat cancer. In the last decade, different strategies to activate NK cells and their use in adoptive NK cell-based therapy have been established. Although NK cells are often considered as a uniform cell population, several phenotypic and functionally distinct NK cells subsets exist in healthy individuals, that are differentially affected by ageing or by apparently innocuous viruses such as cytomegalovirus (CMV). In addition, further alterations in the expression of activating and inhibitory receptors are found in NK cells from cancer patients, likely because of their interaction with tumour cells. Thus, NK cells represent a promising strategy for adoptive immunotherapy of cancer already tested in phase 1/2 clinical trials. However, the existence of NK cell subpopulations expressing different patterns of activating and inhibitory receptors and different functional capacities, that can be found to be altered not only in cancer...Continue Reading

References

Oct 7, 1997·The Journal of Experimental Medicine·S SivoriA Moretta
Jun 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hamish R C SmithWayne M Yokoyama
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William Larry GluckMaurice Wolin
May 6, 2004·Cancer Immunology, Immunotherapy : CII·Raquel TarazonaRafael Solana
Mar 18, 2005·Annual Review of Immunology·Lewis L Lanier
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephen M AnsellThomas E Witzig
Dec 1, 2006·Immunity & Ageing : I & a·Shivani M ChidrawarPaul A H Moss
Jun 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jeremy B SwannMark J Smyth
Feb 13, 2008·PLoS Pathogens·Min FangLuis J Sigal
Feb 16, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael BoyiadzisFrances T Hakim
Feb 29, 2008·Mechanisms of Ageing and Development·Shoko NogusaElizabeth M Gardner
Feb 24, 2009·Blood·Laura ChiossoneThierry Walzer
Mar 14, 2009·Lancet·James L M FerraraErnst Holler
Apr 23, 2009·Cancer Research·Hiroyuki FujisakiDario Campana
May 5, 2009·The Korean journal of laboratory medicine·Duck Cho, Dario Campana
May 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anne-Hélène PilletThierry Rose
Oct 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Noa StanietskyOfer Mandelboim
Jan 1, 2010·Bio-medical Materials and Engineering·Olivia CaundayJean François Stoltz
Jan 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey E RubnitzWing Leung
Jul 14, 2010·BioFactors·Norberto W Zwirner, Carolina I Domaica

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

© 2021 Meta ULC. All rights reserved